BioNexus Gene Lab Corp (Nasdaq:BGLC)
N/A • N/A
CIK 1737523
Company
BioNexus Gene Lab Corp. is a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.
Address
N/A
N/A
Employees
None
None
Stock Info
Close
$0.8520
$0.8520
Day Range
0.8500 - 1.0700
0.8500 - 1.0700
52 Week Range
0.3100 - 17.8800
0.3100 - 17.8800
Average volume
1.63M
1.63M
Short Interest
922.18K (02/15/24)
922.18K (02/15/24)
% of Float Shorted
13.04%
13.04%
Market Cap
$19.04M
$19.04M
Revenue
N/A
N/A
Net Income
N/A
N/A
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
SEC filings
Date | Form | Event |
---|---|---|
5 Sep, 2024 | 8-K | |
28 Aug, 2024 | 8-K | |
26 Aug, 2024 | 8-K | |
14 Aug, 2024 | 10-Q | |
5 Jul, 2024 | 8-K/A | |
6 Jun, 2024 | UPLOAD | |
31 May, 2024 | 10-K/A | |
31 May, 2024 | 10-Q/A | |
31 May, 2024 | 10-Q/A | |
31 May, 2024 | 10-Q/A | |
31 May, 2024 | 10-K/A | |
23 May, 2024 | CORRESP | |
15 May, 2024 | 10-Q | |
9 May, 2024 | 8-K | |
6 May, 2024 | UPLOAD | |
18 Apr, 2024 | 8-K | |
16 Apr, 2024 | 10-K | |
1 Apr, 2024 | 8-K | |
28 Mar, 2024 | NT 10-K | |
26 Mar, 2024 | 10-Q/A | |
29 Feb, 2024 | DEF 14C | |
26 Jan, 2024 | PRE 14C | |
23 Jan, 2024 | SC 13G | |
17 Jan, 2024 | SC 13D | |
20 Nov, 2023 | 10-Q | |
14 Nov, 2023 | NT 10-Q | |
13 Nov, 2023 | 8-K | |
3 Nov, 2023 | 8-K | |
30 Oct, 2023 | 8-K/A | |
17 Oct, 2023 | SC 13G | |
16 Oct, 2023 | 8-K | CEO Change |
11 Oct, 2023 | 8-K | CEO Change |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
7 Sep, 2023 | 8-K | |
16 Aug, 2023 | 10-Q | |
14 Aug, 2023 | NT 10-Q | |
24 Jul, 2023 | 8-K | |
21 Jul, 2023 | 424B4 | |
20 Jul, 2023 | CERT | |
20 Jul, 2023 | 8-K | |
19 Jul, 2023 | EFFECT | |
19 Jul, 2023 | 8-A12B | |
17 Jul, 2023 | S-1/A | |
5 Jul, 2023 | S-1/A | |
17 May, 2023 | DEF 14C | |
9 May, 2023 | S-1/A | |
9 May, 2023 | 10-Q | |
31 Mar, 2023 | 10-K | |
10 Mar, 2023 | DEFR14C | |
21 Feb, 2023 | DEF 14C | |
14 Feb, 2023 | S-1 | |
10 Feb, 2023 | PRE 14C | |
14 Nov, 2022 | 10-Q | |
15 Aug, 2022 | 8-K | CEO Change |
15 Aug, 2022 | 10-Q | |
16 May, 2022 | 10-Q | |
6 Apr, 2022 | 10-K | |
1 Apr, 2022 | NT 10-K | |
15 Nov, 2021 | 10-Q | |
12 Aug, 2021 | 10-Q | |
18 May, 2021 | 10-Q | |
17 May, 2021 | NT 10-Q | |
30 Mar, 2021 | 10-K | |
11 Mar, 2021 | 8-K/A | |
7 Jan, 2021 | 8-K |
Last update:2024-03-06 12:48:42.640632
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.